SCHEMBL7000855

SCHEMBL7000855

O=C1C(=Cc2ccc([N+](=O)[O-])cc2)Cc2ccccc21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.78
SMN1; SMN2 Q16637 1/20 0.78
CASP3 P42574 1/20 0.78
RAB9A P51151 1/20 0.78
SENP8 Q96LD8 1/20 0.78
SENP7 Q9BQF6 1/20 0.78
SENP6 Q9GZR1 1/20 0.78
MAOB P27338 4/20 0.68
MIF P14174 3/20 0.68
MAOA P21397 2/20 0.68
APP P05067 1/20 0.62
CYP19A1 P11511 2/20 0.61
TNF P01375 2/20 0.61
PTGS2 P35354 1/20 0.58
ALDH1A1 P00352 2/20 0.57
LMNA P02545 1/20 0.57
HPGD P15428 1/20 0.57
STK17B O94768 1/20 0.57
ACHE P22303 3/20 0.55
BCHE P06276 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000852 1.00 MAPT (0.78) MAPTSMN1; SMN2CASP3RAB9ASENP8
SCHEMBL8549041 0.87 MAPT (1.00) MAPTSMN1; SMN2CASP3RAB9ASENP8
SCHEMBL8549042 0.87 MAPT (1.00) MAPTSMN1; SMN2CASP3RAB9ASENP8
SCHEMBL7701180 0.85 MAPT (0.79) MAPTSMN1; SMN2CASP3RAB9ASENP8
SCHEMBL7701179 0.85 MAPT (0.79) MAPTSMN1; SMN2CASP3RAB9ASENP8
SCHEMBL14033556 0.82 MIF (0.81) MAPTMAOBMIFMAOACYP19A1
SCHEMBL3694617 0.81 MAOB (1.00) MAPTMAOBMIFMAOACYP19A1
SCHEMBL30977980 0.81 MAOB (1.00) MAPTMAOBMIFMAOACYP19A1
SCHEMBL30462577 0.81 MAOB (1.00) MAPTMAOBMIFMAOACYP19A1
SCHEMBL2981650 0.81 MAOB (1.00) MAPTMAOBMIFMAOACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165544-B1 SUBSTITUTED 1,4-DIHYDROINDENO[1,2-C]PYRAZOLES AS INHIBITORS OF TYROSINE KINASE KNOLL GMBH (DE) 2003-08-06 EP disclosed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
EP-1268437-A1 INHIBITORS OF PROTEIN KINASES Knoll GmbH (DE) 2003-01-02 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
CN-1368970-A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase KNOLL GMBH (DE) 2002-09-11 CN disclosed
WO-2002030908-A1 INHIBITORS OF PROTEIN KINASES KNOLL GMBH (DE) 2002-04-18 WO disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
US-6297238-B1 3-ARYL PYRAZOLES WITH 4,5(3,4)-BICYCLIC RING FUSION WHICH ARE INHIBITORS OF PROTEIN KINASES PARTICULARLY TYROSINE KINASES AND SERINE/THREONINE KINASES BASF AKTIENGESELLSCHAFT (DE) 2001-10-02 US disclosed
EP-0084671-B1 ANILINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COMBATING UNDESIRED PLANT GROWTH, AND INTERMEDIATES FOR THEIR PREPARATION BASF Aktiengesellschaft (DE) 1986-03-05 EP disclosed
EP-0084671-A2 Aniline derivatives, process for their preparation and their use in combating undesired plant growth, and intermediates for their preparation BASF Aktiengesellschaft (DE) 1983-08-03 EP disclosed